KG
EW icon

Kilter Group’s Edwards Lifesciences EW Stock Holding History

Kilter Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.23K Sell
91
-8
-8% -$670 ﹤0.01% 529
2026
Q1 		$7.93K Sell
99
-10
-9% -$824 ﹤0.01% 476
2025
Q4 		$9.29K Buy
109
+20
+22% +$1.64K ﹤0.01% 370
2025
Q3 		$6.92K Buy
89
+5
+6% +$391 ﹤0.01% 393
2025
Q2 		$6.57K Buy
+84
New +$6.26K ﹤0.01% 344

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Kilter Group's EW Position: Q2 2026 in Review

Kilter Group reduced its Edwards Lifesciences (EW) stake by 8.1% in Q2 2026, selling an estimated $670 and leaving 91 shares worth $8.23K. The position accounts for ﹤0.01% of the portfolio, ranked #529.

Kilter Group first reported a position in EW in Q2 2025 and has held it in 5 quarters since. The position peaked at $9.29K in Q4 2025. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Kilter Group held 91 shares of Edwards Lifesciences worth $8.23K as of Q2 2026.
  • Kilter Group sold 8 Edwards Lifesciences shares in Q2 2026, an estimated $670.
  • Edwards Lifesciences made up ﹤0.01% of Kilter Group's portfolio in Q2 2026, its #529 holding.
  • Kilter Group first reported a position in Edwards Lifesciences in Q2 2025 and has held it in 5 quarters since.
  • Kilter Group's Edwards Lifesciences position peaked at $9.29K in Q4 2025.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.